Revvity Board Declares Quarterly Dividend
Revvity (NYSE: RVTY) announced that its Board of Directors has declared a quarterly dividend of $0.07 per share of common stock. The dividend will be paid on February 7, 2025, to shareholders of record as of the close of business on January 17, 2025.
Revvity (NYSE: RVTY) ha annunciato che il suo Consiglio di Amministrazione ha dichiarato un dividendo trimestrale di $0.07 per azione di azioni ordinarie. Il dividendo sarà pagato il 7 febbraio 2025 agli azionisti registrati alla chiusura degli affari il 17 gennaio 2025.
Revvity (NYSE: RVTY) anunció que su Junta Directiva ha declarado un dividendo trimestral de $0.07 por acción de acciones comunes. El dividendo se pagará el 7 de febrero de 2025 a los accionistas registrados al cierre de operaciones del 17 de enero de 2025.
레버리티 (NYSE: RVTY)는 이사회를 통해 분기 배당금으로 주당 $0.07을 선언했다고 발표했습니다. 배당금은 2025년 2월 7일에 지급되며, 2025년 1월 17일 영업 종료 시점에 주주로 등록된 사람들에게 지급됩니다.
Revvity (NYSE: RVTY) a annoncé que son Conseil d'Administration a déclaré un dividende trimestriel de 0,07 $ par action ordinaire. Le dividende sera versé le 7 février 2025 aux actionnaires enregistrés à la clôture des affaires le 17 janvier 2025.
Revvity (NYSE: RVTY) gab bekannt, dass der Vorstand eine Quartalsdividende von $0.07 pro Aktie der Stammaktien erklärt hat. Die Dividende wird am 7. Februar 2025 an die Aktionäre ausgezahlt, die am Ende des Geschäftstags am 17. Januar 2025 registriert sind.
- Regular quarterly dividend payment of $0.07 per share maintained, showing consistent shareholder returns
- None.
About Revvity
At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.
With 2023 revenue of more than
Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241024806358/en/
Media Relations:
Chet Murray
(781) 462-5126
chet.murray@revvity.com
Investor Relations:
Steve Willoughby
steve.willoughby@revvity.com
Source: Revvity
FAQ
When is Revvity (RVTY) paying its next dividend?
What is the dividend amount for Revvity (RVTY) stock?